DayDrop Triple Action

Unique triple-action formula with hyaluronic acid, ectoin and carboxymethylcellulose. Phosphate-free and preservative-free.

With sustained-release technology that releases ectoin for up to 12 hours.

Main ingredients: Ectoin, hyaluronic acid and carboxymethylcellulose (CMC)
Presentation (format): Multidose: 10 mL container with OSD (Ophthalmic Squeeze Dispenser) technology.Single-dose: Low-density polyethylene (LDPE) containers: 0.4 mL x 30, 20 or 5 units.
Certification: Medical Device
Shelf life and PAO: 3 yearsPAO: 12 months (multidose)
Technology: Sustained release of ectoin

Advantages

Triple action: combines hydration, lubrication and protection in a single formula.
Sustained-release technology that releases ectoin for up to 12 hours.
Longer residence time on the ocular surface.

Indications

For the relief of ocular dryness and irritation caused by environmental factors, prolonged use of screens or contact lenses, and/or certain ocular conditions associated with these symptoms.

Properties

• Relieves ocular dryness and the sensation of dry eyes.

• Relieves ocular irritation.

• Protects against external allergens, relieving allergy symptoms.

• Compatible with contact lenses.

• Preservative-free and phosphate-free, ensuring excellent tolerability.

Directions for use

Instil one or two drops into each eye twice daily, or as often as directed by your specialist.

Technology

Sustained release of ectoin.

The technology combines high-molecular-weight hyaluronic acid, which forms a stable matrix and regulates the gradual release of ectoin, with CMC, which improves adhesion to the ocular surface.

This combination enables controlled release of ectoin and prolongs its residence time in the tear film.

Triple action: combines hydration, lubrication and protection in a single formula.
Sustained-release technology that releases ectoin for up to 12 hours.
Longer residence time on the ocular surface.